BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24007441)

  • 21. Rapamycin and CTLA4Ig synergize to induce stable mixed chimerism without the need for CD40 blockade.
    Pilat N; Klaus C; Schwarz C; Hock K; Oberhuber R; Schwaiger E; Gattringer M; Ramsey H; Baranyi U; Zelger B; Brandacher G; Wrba F; Wekerle T
    Am J Transplant; 2015 Jun; 15(6):1568-79. PubMed ID: 25783859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions.
    Taylor PA; Lees CJ; Waldmann H; Noelle RJ; Blazar BR
    Blood; 2001 Jul; 98(2):467-74. PubMed ID: 11435318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive.
    Zhai Y; Meng L; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW
    J Immunol; 2003 Mar; 170(6):3024-8. PubMed ID: 12626556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of CD8+ T cell-derived CD40 signals is necessary but not sufficient for Foxp3+ induced regulatory T cell generation in vivo.
    Liu D; Ferrer IR; Konomos M; Ford ML
    J Immunol; 2013 Aug; 191(4):1957-64. PubMed ID: 23858029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of anti-CD40 antibody-mediated costimulation blockade on non-Gal antibody production and heterotopic cardiac xenograft survival in a GTKO.hCD46Tg pig-to-baboon model.
    Mohiuddin MM; Singh AK; Corcoran PC; Hoyt RF; Thomas ML; Lewis BG; Eckhaus M; Dabkowski NL; Belli AJ; Reimann KA; Ayares D; Horvath KA
    Xenotransplantation; 2014; 21(1):35-45. PubMed ID: 24164510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD11b is a novel alternate receptor for CD154 during alloimmunity.
    Liu D; Ford ML
    Am J Transplant; 2020 Aug; 20(8):2216-2225. PubMed ID: 32149455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The CD154-CD40 T cell costimulation pathway is required for host sensitization of CD8(+) T cells by skin grafts via direct antigen presentation.
    Zhai Y; Shen XD; Gao F; Coito AJ; Wasowska BA; Salama A; Schmitt I; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW
    J Immunol; 2002 Aug; 169(3):1270-6. PubMed ID: 12133948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Critical role for CD8 T cells in allograft acceptance induced by DST and CD40/CD154 costimulatory blockade.
    Gao D; Lunsford KE; Eiring AM; Bumgardner GL
    Am J Transplant; 2004 Jul; 4(7):1061-70. PubMed ID: 15196062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blockade of CD28-B7, but not CD40-CD154, prevents costimulation of allogeneic porcine and xenogeneic human anti-porcine T cell responses.
    Lee RS; Yamada K; Womer KL; Pillsbury EP; Allison KS; Marolewski AE; Geng D; Thall AD; Arn JS; Sachs DH; Sayegh MH; Madsen JC
    J Immunol; 2000 Mar; 164(6):3434-44. PubMed ID: 10706740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation.
    Molano RD; Berney T; Li H; Cattan P; Pileggi A; Vizzardelli C; Kenyon NS; Ricordi C; Burkly LC; Inverardi L
    Diabetes; 2001 Feb; 50(2):270-6. PubMed ID: 11272136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD40 ligand-specific antibodies synergize with cyclophosphamide to promote long-term transplantation tolerance across MHC barriers but inhibit graft-vs-leukemia effects of transplanted cells.
    Prigozhina TB; Gurevitch O; Elkin G; Morecki S; Yakovlev E; Slavin S
    Exp Hematol; 2003 Jan; 31(1):81-8. PubMed ID: 12543110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined Anti-CD154/CTLA4Ig Costimulation Blockade-Based Therapy Induces Donor-Specific Tolerance to Vascularized Osteomyocutaneous Allografts.
    Lin CH; Wang YL; Anggelia MR; Chuang WY; Cheng HY; Mao Q; Zelken JA; Lin CH; Zheng XX; Lee WP; Brandacher G
    Am J Transplant; 2016 Jul; 16(7):2030-41. PubMed ID: 26914847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-CD40 therapy extends renal allograft survival in rhesus macaques.
    Pearson TC; Trambley J; Odom K; Anderson DC; Cowan S; Bray R; Lin A; Hollenbaugh D; Aruffo A; Siadak AW; Strobert E; Hennigar R; Larsen CP
    Transplantation; 2002 Oct; 74(7):933-40. PubMed ID: 12394833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance.
    Wekerle T; Sayegh MH; Ito H; Hill J; Chandraker A; Pearson DA; Swenson KG; Zhao G; Sykes M
    Transplantation; 1999 Nov; 68(9):1348-55. PubMed ID: 10573075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human CD34(+) blood cells induce T-cell unresponsiveness to specific alloantigens only under costimulatory blockade.
    Arpinati M; Terragna C; Chirumbolo G; Rizzi S; Urbini B; Re F; Tura S; Baccarani M; Rondelli D
    Exp Hematol; 2003 Jan; 31(1):31-8. PubMed ID: 12543104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donor-Specific Regulatory T Cell-Mediated Immune Tolerance in an Intrahepatic Murine Allogeneic Islet Transplantation Model with Short-Term Anti-CD154 mAb Single Treatment.
    Lee SJ; Kim HJ; Byun NR; Park CG
    Cell Transplant; 2020; 29():963689720913876. PubMed ID: 32216448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of donor-specific transfusion sources: unique failure of bone marrow cells to induce prolonged skin allograft survival with anti-CD154 monoclonal antibody.
    Markees TG; Pearson T; Cuthbert A; Pearson AL; Shultz LD; Leif J; Phillips NE; Mordes JP; Greiner DL; Rossini AA
    Transplantation; 2004 Dec; 78(11):1601-8. PubMed ID: 15591948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
    Yuan X; Dong VM; Coito AJ; Waaga AM; Salama AD; Benjamin CD; Sayegh MH; Chandraker A
    Transplantation; 2002 Jun; 73(11):1736-42. PubMed ID: 12084995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts.
    Williams MA; Trambley J; Ha J; Adams AB; Durham MM; Rees P; Cowan SR; Pearson TC; Larsen CP
    J Immunol; 2000 Dec; 165(12):6849-57. PubMed ID: 11120808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donor-antigen Inoculation in the Testis Promotes Skin Allograft Acceptance Induced by Conventional Costimulatory Blockade via Induction of CD8 + CD122+ and CD4 + CD25+ Regulatory T Cells.
    Cong L; Wang SF; Zhao ZL; Yang RY
    Transplantation; 2016 Apr; 100(4):763-71. PubMed ID: 26569069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.